"Our mission is to provide comprehensive, superior-quality and cost-effective cardiovascular care."

During the past decade, Aurora Denver Cardiology Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 11 clinical trials were completed, i.e. on average, 137.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora Denver Cardiology Associates" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "United Therapeutics" with 3 trials sponsored, "Biotronik, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Denver Cardiology Associates" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator, "Aurora Denver Cardiology Associates" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Aurora Denver Cardiology Associates" are "Atrial Fibrillation" (6 trials), "Pulmonary Arterial Hypertension" (3 trials), "Angina Pectoris" (2 trials), "Congestive Heart Failure" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (2 trials). Many other conditions were trialed in "Aurora Denver Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Aurora Denver Cardiology Associates" are "Drug" (20 trials), "Device" (8 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Oral treprostinil" (3 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials) and "AMPLATZER Septal Occluder" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aurora Denver Cardiology Associates" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aurora Denver Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Aurora Denver Cardiology Associates, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora Denver Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".